ACTUACIÓN FRENTE A COVID19 EN RECEPTORES DE TRASPLANTE DE PROGENITORES HEMATOPOYÉTICOS Y PACIENTES ONCOHEMATOLÓGICOS (COVID-19) (GETH-COV-2020-01)

Study type

• Study topic:
  Other
• Study topic, other:
  Diagnostic procedure
• Study type:
  Non-interventional study
• Scope of the study:
  Disease epidemiology
• Data collection methods:
  Primary data collection

Non-interventional study

• Non-interventional study design:
  Cohort

Study drug and medical condition

• Medical condition to be studied:
  Diagnostic procedure
• Additional medical condition(s):
  HEMATOLOGIC PATIENT WITH CODIV-19 INFECTION

Population studied

• Short description of the study population:
  TPH/ONCOHEMATOLOGICAL patients will be included, that is to say, immunosuppressed patients such as the recipients of allogeneic or autologous transplants of haematopoietic progenitors (alo or auto-TPH), of CAR-T therapy and oncohaematological patients in chemotherapeutic and/or immunosuppressive treatment from centres participating in the GETH.
• Age groups:
  • Paediatric Population (< 18 years)
  • Adults (18 to < 46 years)
  • Adults (46 to < 65 years)
  • Adults (65 to < 75 years)
  • Adults (75 to < 85 years)
  • Adults (85 years and over)
• Special population of interest:
  Immunocompromised
• Estimated number of subjects:
  500

Study design details

• Main study objective:
  INCIDENT
• Outcomes:
  use of treatments or interactions resulting from this
• Data analysis plan:
  Análisis estadístico: JULIO 2020